Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| HOLX | HOLOGIC INC | 2025-12-02 08:10:25 | 75.08 | 0.24 | 0.32 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOLX | 0000859737 | HOLOGIC INC | US4364401012 | 549300DYP6F5ZJL0LB74 | 042902449 | Nasdaq | 3844 | X-Ray Apparatus & Tubes & Related Irradiation Apparatus | 0928 | DE | 250 CAMPUS DRIVE | MARLBOROUGH | MA | 01752 | UNITED STATES | US | 5082632900 | 250 CAMPUS DRIVE, MARLBOROUGH, MA, 01752 | 250 CAMPUS DRIVE, MARLBOROUGH, MA, 01752 | — | Medical Technology | 1985 | Stephen P. MacMillan | 7,070 | https://www.hologic.com/ | 13,566,017,923 | 302,438,000 | 222,905,228 | Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging. | 2025-11-27 15:14:00 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 13,566,017,923 | -4,490,671,027 | -24.8698 | 222,905,228 | -4,035,989 | -1.7784 |
| 2024 | 18,056,688,950 | -1,581,245,529 | -8.052 | 226,941,217 | -13,061,585 | -5.4423 |
| 2023 | 19,637,934,479 | 880,088,208 | 4.6918 | 240,002,802 | -5,830,957 | -2.3719 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Essex D. Mitchell | Chief Operating Officer | 2024 | 592,692 | 0 | 1,944,766 | 725,000 | 196,272 | 4,083,725 |
| John M. Griffin | General Counsel | 2024 | 644,231 | 0 | 1,555,966 | 550,000 | 223,858 | 3,474,051 |
| Stephen P. Macmillan | Chief Executive Officer, Chairman, President | 2024 | 1,212,628 | 0 | 9,141,468 | 1,990,413 | 537,275 | 15,819,261 |
| Karleen M. Oberton | Chief Financial Officer | 2024 | 694,231 | 0 | 1,944,766 | 600,000 | 226,446 | 4,090,438 |
| Jan Verstreken | Group President | 2024 | 693,399 | 0 | 1,555,966 | 611,323 | 225,211 | 3,585,895 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 7,070 |
| 2024 | 7,063 |
| 2023 | 6,990 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 4,100,500,000 | 4,030,300,000 | 4,030,400,000 |
| Cost Of Revenue | 1,599,400,000 | 39,200,000 | 179,500,000 |
| Gross Profit | 2,117,900,000 | 2,227,800,000 | 2,071,500,000 |
| Research And Development Expenses | 248,200,000 | 272,800,000 | 294,300,000 |
| General And Administrative Expenses | 449,300,000 | 409,400,000 | 392,400,000 |
| Operating Expenses | 1,403,600,000 | 1,345,200,000 | 1,403,100,000 |
| Operating Income | 714,300,000 | 882,600,000 | 668,400,000 |
| Net Income | 565,700,000 | 789,500,000 | 456,000,000 |
| Earnings Per Share Basic | 2.5 | 3.35 | 1.85 |
| Earnings Per Share Diluted | 2.49 | 3.32 | 1.83 |
| Weighted Average Shares Outstanding Basic | 226,156,000 | 235,723,000 | 246,772,000 |
| Weighted Average Shares Outstanding Diluted | 227,573,000 | 237,553,000 | 248,831,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,959,500,000 | 2,160,200,000 | 2,722,500,000 |
| Marketable Securities Current | 243,200,000 | 173,400,000 | — |
| Accounts Receivable | 600,800,000 | 600,400,000 | 625,600,000 |
| Inventories | 679,400,000 | 679,800,000 | 617,600,000 |
| Non Trade Receivables | 37,400,000 | 37,500,000 | 33,000,000 |
| Other Assets Current | — | — | — |
| Total Assets Current | 3,668,100,000 | 3,823,300,000 | 4,184,500,000 |
| Marketable Securities Non Current | 0 | 96,400,000 | — |
| Property Plant And Equipment | 559,600,000 | 537,800,000 | 517,000,000 |
| Other Assets Non Current | 557,500,000 | 410,800,000 | 267,900,000 |
| Total Assets Non Current | 5,346,800,000 | 5,332,700,000 | 4,954,800,000 |
| Total Assets | 9,014,900,000 | 9,156,000,000 | 9,139,300,000 |
| Accounts Payable | 193,400,000 | 203,800,000 | 175,200,000 |
| Deferred Revenue | 199,700,000 | 212,900,000 | 199,200,000 |
| Short Term Debt | 2,900,000 | 37,500,000 | 287,000,000 |
| Other Liabilities Current | 577,700,000 | 579,700,000 | 534,600,000 |
| Total Liabilities Current | 977,200,000 | 1,037,200,000 | 1,207,300,000 |
| Long Term Debt | 2,507,900,000 | 2,534,600,000 | 2,818,200,000 |
| Other Liabilities Non Current | 420,000,000 | 406,300,000 | 334,600,000 |
| Total Liabilities Non Current | — | — | — |
| Total Liabilities | — | — | — |
| Common Stock | 3,000,000 | 3,000,000 | 3,000,000 |
| Retained Earnings | 3,411,500,000 | 2,845,800,000 | 2,056,300,000 |
| Accumulated Other Comprehensive Income | -100,800,000 | -111,500,000 | -147,600,000 |
| Total Shareholders Equity | 5,047,900,000 | 5,130,000,000 | 5,016,900,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 190,900,000 | 209,700,000 | 233,800,000 |
| Share Based Compensation Expense | 84,300,000 | 82,300,000 | 79,600,000 |
| Other Non Cash Income Expense | -43,400,000 | -45,900,000 | -28,900,000 |
| Change In Accounts Receivable | -7,800,000 | -41,000,000 | 1,500,000 |
| Change In Inventories | 1,300,000 | 47,400,000 | 4,900,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -11,300,000 | 22,200,000 | -23,000,000 |
| Change In Other Liabilities | -32,300,000 | 73,400,000 | -14,200,000 |
| Cash From Operating Activities | 1,057,100,000 | 1,285,200,000 | 1,051,200,000 |
| Purchases Of Marketable Securities | 146,900,000 | 267,700,000 | — |
| Sales Of Marketable Securities | 176,000,000 | — | — |
| Acquisition Of Property Plant And Equipment | 58,800,000 | 130,200,000 | 150,200,000 |
| Acquisition Of Business | 321,500,000 | 297,300,000 | 5,000,000 |
| Other Investing Activities | 2,900,000 | 2,000,000 | 7,400,000 |
| Cash From Investing Activities | -482,700,000 | -781,000,000 | -152,100,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 752,900,000 | 835,100,000 | 474,800,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | 0 |
| Other Financing Activities | 38,800,000 | 37,800,000 | 43,000,000 |
| Cash From Financing Activities | -777,200,000 | -1,108,600,000 | -483,200,000 |
| Change In Cash | -200,700,000 | -595,500,000 | 416,200,000 |
| Cash At End Of Period | 1,959,500,000 | 2,160,200,000 | 2,722,500,000 |
| Income Taxes Paid | 224,300,000 | 137,900,000 | 296,100,000 |
| Interest Paid | 112,900,000 | 117,100,000 | 105,400,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 2.5 | 3.35 | 1.85 |
| Price To Earnings Ratio | 26.884 | 24.1254 | 37.5135 |
| Earnings Growth Rate | -25.3731 | 81.0811 | -64.2857 |
| Price Earnings To Growth Ratio | -1.0595 | 0.2975 | -0.5835 |
| Book Value Per Share | 35.5405 | 34.4421 | 32.143 |
| Price To Book Ratio | 1.8911 | 2.3465 | 2.1591 |
| Ebitda | 1,098,000,000 | 1,259,200,000 | 1,097,000,000 |
| Enterprise Value | 15,751,244,760 | 19,463,032,860 | 17,508,676,800 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.4974 | 0.5014 | 0.6189 |
| Capital Expenditures | 212,700,000 | 230,500,000 | 269,200,000 |
| Free Cash Flow | 844,400,000 | 1,054,700,000 | 782,000,000 |
| Return On Equity | 0.1121 | 0.1539 | 0.0909 |
| One Year Beta | 0.3268 | 0.2651 | 0.7131 |
| Three Year Beta | 0.454 | 0.5814 | 0.6477 |
| Five Year Beta | 0.5267 | 0.7546 | 0.8136 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Liddy Anne M. | General Counsel | 2025-11-14 | 337 | D | 28,237 |
| COHN BENJAMIN JORDAN | Principal Accounting Officer | 2025-11-14 | 187 | D | 17,884 |
| Mitchell Essex D | Chief Operating Officer | 2025-11-14 | 1,342 | D | 77,610 |
| Oberton Karleen Marie | Chief Financial Officer | 2025-11-14 | 1,333 | D | 150,735 |
| Schneiders Jennifer M | President, Diag. Solutions | 2025-11-14 | 561 | D | 41,318 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas R Carper | Senator | 2023-02-02 | Sale (Full) | 2023-01-11 | Spouse | $1,001 - $15,000 |
| John F Reed | Senator | 2019-03-18 | Sale (Full) | 2019-02-28 | Self | $1,001 - $15,000 |
| John F Reed | Senator | 2018-12-12 | Purchase | 2018-11-28 | Self | $1,001 - $15,000 |
| Susan M Collins | Senator | 2018-06-12 | Sale (Full) | 2018-05-04 | Spouse | $15,001 - $50,000 |
| Susan M Collins | Senator | 2017-05-10 | Purchase | 2016-12-01 | Spouse | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Gilbert Cisneros | 2025-04-07 | CA31 | Sale | 2025-03-31 | — | $1,001 - $15,000 |
| Susie Lee | 2022-12-29 | NV03 | Sale | 2022-11-30 | Joint | $1,001 - $15,000 |
| Susie Lee | 2022-08-13 | NV03 | Purchase | 2021-09-30 | Joint | $1,001 - $15,000 |
| Tom Malinowski | 2021-03-06 | NJ07 | Sale | 2021-02-23 | — | $15,001 - $50,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 74,782,894 | 1,108,008 | 67.4931 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 415,693 | 6,159 | 67.4936 |
| Bell Investment Advisors, Inc | 2025-09-30 | 22,272 | 330 | 67.4909 |
| Ovata Capital Management Ltd | 2025-09-30 | 532,766 | 7,894 | 67.49 |
| Wilmington Savings Fund Society, FSB | 2025-09-30 | 2,835 | 42 | 67.5 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYHAX | 2,015 | 135,992.35 | 0.5552 |
| RYDEX SERIES FUNDS | 2025-09-30 | Investor Class | RYHIX | 2,015 | 135,992.35 | 0.5552 |
| CYBER HORNET TRUST | 2025-09-30 | No Load Shares | INDEX | 624 | 42,113.76 | 0.0279 |
| Voya INVESTORS TRUST | 2025-09-30 | Voya VACS Index Series S Portfolio | VVIPX | 16,867 | 1,138,353.83 | 0.0261 |
| Voya INVESTORS TRUST | 2025-09-30 | Class ADV | ISIVX | 10,153 | 685,225.97 | 0.0257 |